Invention Grant
- Patent Title: Compounds and anti-tumor NQO1 substrates
-
Application No.: US14993029Application Date: 2016-01-11
-
Publication No.: US09611266B2Publication Date: 2017-04-04
- Inventor: Paul J. Hergenrother , David A. Boothman , Joseph S. Bair , Rahul Palchaudhuri , Elizabeth I. Parkinson
- Applicant: The Board of Trustees of the University of Illinois , The Board of Regents of the University of Texas System
- Applicant Address: US IL Urbana US TX Austin
- Assignee: The Board of Trustees of the University of Illinois,The Board of Regents of the University of Texas System
- Current Assignee: The Board of Trustees of the University of Illinois,The Board of Regents of the University of Texas System
- Current Assignee Address: US IL Urbana US TX Austin
- Agency: Haukaas Fortius PLLC
- Agent Michael H. Haukaas
- Main IPC: A61K31/675
- IPC: A61K31/675 ; C07D471/00 ; C07D471/04 ; A61K31/47 ; C07H15/26 ; C07F9/6561

Abstract:
Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
Public/Granted literature
- US20160122348A1 COMPOUNDS AND ANTI-TUMOR NQO1 SUBSTRATES Public/Granted day:2016-05-05
Information query